Author: Dr. Donna Murdoch

Google’s newest project involves a subject that affects most people sooner or later: The company has announced the formation of a spinoff, Calico, that will focus on finding solutions for issues surrounding aging and illness. Although details are few, it’s expected that Calico will take advantage of Google’s massive databases to provide new insights into, among other things, extending human lifespans. It will be led by Arthur Levinson, who used to head up Genentech, a corporation considered by many to be a pioneer in the biotechnology industry.

via Google’s Next Big Search: How And Why We Age | IdeaFeed | Big Think.

Technology is advancing so rapidly that most of today’s industry leaders will slip into oblivion by the end of this decade. The only companies that will survive are those that invest heavily in research — and take big risks. Nothing illustrates the difference between companies better than Facebook and Google. Google is exploring uncharted territory and staking its claims to the next trillion-dollar market opportunities, while Facebook is mired in the past and squeezing every penny it can out of its customers. Unless it happens to luck out by buying the right company, it seems to me, Facebook is doomed.

via Why startups should look to Google, not Facebook, as a role model | VentureBeat.